JPRN-UMIN000019049尚未招募2 期
Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer - Phase2 study of itraconazole,abraxane, carboplatin and avastin for advanced nonsquamous nonsmall cell lung cancer
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •judged inappropriate by doctors
研究者
相似试验
已完成
2 期
Phase II study of Carboplatin, Paclitaxel and Bevacizumab in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion.JPRN-UMIN000006767Shizuoka Cancer Center32
进行中（未招募）
2 期
OGIK2002(RESTART)Treatment-naive advanced non-squamous non-small cell lung cancerNSCLC, advanced, renal dysfunctionD002289JPRN-jRCTs071200102Okamoto Isamu25
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancerntreated Extensive-Stage Small Cell Lung CancerMedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000358-20-LVG1 Therapeutics100
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung CancerEUCTR2017-000358-20-BGG1 Therapeutics100
进行中（未招募）
1 期
Study of Carboplatin, Etoposide, and Atezolizumab With or WithoutTrilaciclib (G1T28) in Patients with Untreated Extensive-Stage Small Cell Lung Cancerntreated Extensive-Stage Small Cell Lung CancerMedDRA version: 21.1Level: PTClassification code 10041068Term: Small cell lung cancer extensive stageSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-000358-20-EEG1 Therapeutics100